To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
322
24-hour average pain score measured by Visual Analog Scale
Subject reported pain intensity measured by Visual Analog Scale (0-100)
Time frame: 8 weeks
Western Ontario and McMaster (WOMAC™ ) Osteoarthritis subscales, Pain, Physical Function and Stiffness scores
Self administered, patient-centered, health status questionnaire
Time frame: 8 weeks
Subject's Global Assessment of Arthritis Status
Subject reported assessment of arthritis status measured by Visual Analogue Scale (0-100)
Time frame: 8 weeks
Brief Pain Inventory
Subject reported pain intensity and intereference (scale 0-10)
Time frame: 8 weeks
SF-36v2™ Health Status Survey
There is no formal title for this quality of life survey, this is the only name for this measure. Subject reported quality of life survey
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Site Reference ID/Investigator# 37220
Chandler, Arizona, United States
Site Reference ID/Investigator# 37223
Tempe, Arizona, United States
Site Reference ID/Investigator# 37215
Tucson, Arizona, United States
Site Reference ID/Investigator# 37221
Anaheim, California, United States
Site Reference ID/Investigator# 37222
Burbank, California, United States
Site Reference ID/Investigator# 35956
Chino, California, United States
Site Reference ID/Investigator# 37053
La Mesa, California, United States
Site Reference ID/Investigator# 37218
Lomita, California, United States
Site Reference ID/Investigator# 37227
Milford, Connecticut, United States
Site Reference ID/Investigator# 37229
Boynton Beach, Florida, United States
...and 28 more locations